title: Extended survival in a patient with recurrent and metastatic adrenal cortical carcinoma by aggressive transarterial embolization--a case report.
abstract: The prognosis of inoperable recurrent or metastatic adrenal cortical carcinoma is poor due to lack of effective treatment modalities. We report a case of recurrent and metastatic adrenal cortical carcinoma in which prolonged survival of 58 months was achieved with aggressive three sequential transarterial embolization. It is probably the first reported case with the longest survival by transarterial embolization in the literature to date. A 60-year-old man received operation for left adrenal cortical carcinoma. Liver metastases, tumor bed recurrence, and spleen metastasis were noted during follow-up. Three sequential transarterial embolization for metastatic liver tumors, tumor bed recurrence, and metastatic spleen tumor were performed and resulted in relief of symptoms and prolonged survival of 58 months after recurrence verified. Aggressive transarterial embolization seems to be a safe and effective procedure for symptoms relief, and may prolong survival in the management of inoperable adrenal cortical carcinoma. It can be considered in any patient with inoperable adrenal cortical carcinoma if not contraindicated.
authors.affiliation: Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
authors.forename: Shau-Hsuan
authors.initials: SH
authors.lastname: Li
authors.forename: Cheng-Hua
authors.initials: CH
authors.lastname: Huang
authors.forename: Sheung-Fat
authors.initials: SF
authors.lastname: Ko
authors.forename: Fong-Fu
authors.initials: FF
authors.lastname: Chou
authors.forename: Shun-Chen
authors.initials: SC
authors.lastname: Huang
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D018268:Adrenocortical Carcinoma / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D004621:Embolization, Therapeutic; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D013160:Splenic Neoplasms / Q000556:secondary* / Q000628:therapy; D017741:Survivors